Poongjeon Pharmacy CO.,LTD. (KOSDAQ:298060)

Market Cap	40.98B +65.5%
Revenue (ttm)	1.54B +53.7%
Net Income	-8.24B
EPS	-362.75
Shares Out	8.84M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,080
Average Volume	28,192
Open	4,610.00
Previous Close	4,540.00
Day's Range	4,475.00 - 4,795.00
52-Week Range	3,750.00 - 8,375.00
Beta	0.75
RSI	66.34
Earnings Date	n/a

About KOSDAQ:298060

POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 298060

Financial Performance

In 2024, KOSDAQ:298060's revenue was 824.80 million, an increase of 18.56% compared to the previous year's 695.70 million. Losses were -12.38 billion, -48.35% less than in 2023.